Your browser doesn't support javascript.
loading
Participant Perspectives and Experiences Entering an Intensively Monitored Antiretroviral Pause: Results from the AIDS Clinical Trials Group A5345 Biomarker Study.
Diepstra, Karen L; Barr, Liz; Palm, David; Hogg, Evelyn; Mollan, Katie R; Henley, Laney; Stover, Angela M; Simoni, Jane M; Sugarman, Jeremy; Brown, Brandon; Sauceda, John A; Deeks, Steven; Fox, Lawrence; Gandhi, Rajesh T; Smith, Davey; Li, Jonathan Z; Dubé, Karine.
Afiliação
  • Diepstra KL; UNC Gillings School of Global Public Health, Chapel Hill, North Carolina, USA.
  • Barr L; AIDS Clinical Trials Group (ACTG) Community Scientific Sub-Committee, Baltimore, Maryland, USA.
  • Palm D; Institute of Global Health and Infectious Diseases (IGHID), University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
  • Hogg E; Social & Scientific Systems, a DLH Company, Silver Spring, Maryland, USA.
  • Mollan KR; Center for AIDS Research (CFAR), School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
  • Henley L; UNC Gillings School of Global Public Health, Chapel Hill, North Carolina, USA.
  • Stover AM; UNC Gillings School of Global Public Health, Chapel Hill, North Carolina, USA.
  • Simoni JM; Department of Psychology, University of Washington, Seattle, Washington, USA.
  • Sugarman J; Department of Global Health and Gender, Women, and Sexuality Studies, University of Washington, Seattle, Washington, USA.
  • Brown B; Johns Hopkins Berman Institute for Bioethics, Baltimore, Maryland, USA.
  • Sauceda JA; Department of Social Medicine, Population and Public Health, Center for Healthy Communities, University of California, Riverside School of Medicine, Riverside, California, USA.
  • Deeks S; Division of Prevention Sciences, Center for AIDS Prevention Studies (CAPS), University of California, San Francisco, San Francisco, California, USA.
  • Fox L; Division of HIV, Infectious Diseases and Global Medicine, University of California, San Francisco, San Francisco, California, USA.
  • Gandhi RT; National Institute of Health (NIH) Division of AIDS (DAIDS), Bethesda, Maryland, USA.
  • Smith D; Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Li JZ; Division of Infectious Diseases and Global Health, University of California, San Diego, California, USA.
  • Dubé K; Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
AIDS Res Hum Retroviruses ; 37(6): 489-501, 2021 06.
Article em En | MEDLINE | ID: mdl-33472545
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por HIV / Síndrome da Imunodeficiência Adquirida Tipo de estudo: Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por HIV / Síndrome da Imunodeficiência Adquirida Tipo de estudo: Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article